|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Thoracic Surgery Study Group of Osaka University, Osaka, Japan.
Correspondence to: Noriyoshi Sawabata MD, FCCP, Division of Surgery, Toneyama National Hospital, 51-1 Toneyama, Toyonaka, Osaka 560-8552 Japan; e-mail: nori{at}toneyama.hosp.go.jp
| Abstract |
|---|
|
|
|---|
Design: A trial to assess feasibility.
Settings: National referral hospitals.
Patients: One hundred seven patients were studied, of whom 99 patients were eligible for the study (85 men and 14 women; age range, 15 to 69 years; median age, 23 years), who had undergone VATS for primary spontaneous pneumothorax between July 1996 and June 1998. Apical pneumocysts were resected employing staplers, and residual pneumocysts, if present, were electroablated employing a new tip for the electrosurgery unit (ball shape, 8 mm in diameter, and made of stainless steel).
Measurements and results:
Thirty-three patients (33%) underwent electroablation only for small
(< 2 cm in diameter) pneumocysts (group S), and 11 patients (11%)
underwent electroablation for large (
2 cm in diameter) pneumocysts
(group L). The remaining 55 patients (56%) did not undergo
electroablation because there were no residual pneumocysts (group N).
There were no complications during surgery. The duration of the
operation was significantly shorter (about 20 min on average) for group
N, but there was no significant difference in the amount of blood loss,
the number of applied staples, the duration of drainage, and the
duration of hospital stay. Group S achieved a 100% relapse-free rate
(33 of 33 patients), group L achieved a 64% relapse-free rate (7 of 11
patients), and group N achieved an 89% relapse-free rate (49 of 55
patients) [group S vs group N, p = 0.08; group L vs group N,
p = 0.001; and group S vs group L, p = 0.002].
Conclusion: Electroablation with the M-tip is feasible as a second-line method for the treatment of small pneumocysts following the stapling technique during VATS.
Key Words: ablation bulla electrosurgical unit spontaneous pneumothorax video-assisted thoracoscopic surgery
| Introduction |
|---|
|
|
|---|
Ablation is an inexpensive method of resecting pneumocysts and may be safer than stapled resection in locations that are close to blood vessels. Electrocautery and lasers have been reported to be effective in some patients.11 12 13 However, they are not commonly used because it is difficult to treat pneumocysts with electrocautery using conventional tips without causing damage, and lasers are expensive and not so ubiquitous. A new tip for electrosurgery (the M-tip) has become available. It is ball-shaped, 8 mm in diameter, made of stainless steel, and gives adequate shrinkage of the pleura with little trauma.14
We conducted a study setting the primary end point as the calculation of the relapse-free rate and the secondary end point as the assessment of adverse effects in order to assess the feasibility of electroablation using the M-tip as a second-line method for stapled resection of pneumocysts during VATS.
| Materials and Methods |
|---|
|
|
|---|
Surgical Techniques
Apical lesions were resected employing staplers (model EZ-45;
Ethicon; Tokyo, Japan). Following the stapled resection, the lung was
inflated and observed through video-assisted thoracoscopy. Residual
pneumocysts, if present, were ablated by an electrosurgical unit
employing a new tip that was ball-shaped, 8 mm in diameter, and made of
stainless steel (M-tip; Senko Ika; Tokyo, Japan). This tip can be used
with any electrocoagulator. The ball tip is illustrated in Figure 1 . The power level was set at 20 W using one unit (Bovie X10 U; Hokusan;
Tokyo, Japan) and 10 W using another unit (MS-BM2 U; Senko Ika), and
both units were set on spray coagulation mode. Pneumocysts soaked with
normal saline solution were rubbed with the tip of the
electrocoagulator to obtain adequate shrinkage. Treatment ceased on
white coloration with shrinking, as shown in Figure 2
. Pleurodesis was not undertaken, because the outcome of iatrogenic
pleuritis remains unknown.
|
|
0.05. | Results |
|---|
|
|
|---|
2 cm in diameter; group L), and the remaining
55 patients (56%) did not undergo electroablation because there were
no residual pneumocysts (group N). The following demographic parameters
were not statistically different among the three groups: mean (± SD)
age: group S, 28 ± 11 years; group L, 34 ± 17 years; and group N,
27 ± 14 years (p = 0.3); and gender: group S, 28 men and 5 women;
group L, 10 men and 1 woman; and group N, 47 men and 8 women
(p = 0.9).
Treatment of Pneumocysts
The pneumocysts were treated with staplers or by electrocautery
using the M-tip without any complications. One hundred six lesions were
resected with staplers. A total of 55 lesions were ablated by
electrocautery (ovoid surface, 32 lesions; edge, 32 lesions; site close
to a blood vessel, 5 lesions; and place near the staple, 4 lesions).
Forty-four lesions were small pneumocysts (< 2 cm in diameter), and
11 were large pneumocysts (> 2 cm in diameter).
Operative and Postoperative Parameters
There were no complications during surgery. Comparing the three
groups, the duration of surgery was significantly shorter in
group N. On the other hand, there were no significant differences in
the amount of blood loss, the applied number of staple cassettes, the
duration of drainage, and the duration of hospital stay (Table 1
).
|
|
| Discussion |
|---|
|
|
|---|
The ablation of pneumocysts employing electrocautery or a laser may be safer than the stapling technique when the ablation is applied to pneumocysts close to a blood vessel, because both techniques shrink the pneumocyst with little damage. Moreover, ablation is inexpensive using electrocautery or a laser when many pneumocysts are treated in the same operation, thus making the use of disposable staple cassettes unnecessary for ablation. Once a unit for ablation is set up, there is little difference in the cost between the treatment for a single pneumocyst and for multiple pneumocysts. Suturing or loop ligation also is used as second-line method15 16 17 but ablation is easier to perform than either of these methods.
Wakabayashi11 reported in 1989 that thoracoscopic electrocautery in the treatment of PSP was safe and effective with a success rate of 90% when it was used with a conventional tip. However, this technique was controversial at that time because it was difficult to ablate pneumocysts using a conventional tip without adverse effects, such as the rupture of the pneumocysts during surgery or excessive burning of the lung, possibly leading to delayed pneumothorax.18 LoCicero and colleagues19 20 21 reported in the late 1980s that a carbon dioxide laser was more effective than electroablation in sealing air leaks from the lungs. Following these studies, Wakabayashi and his coworkers12 reported in 1990 that it was possible to treat all types of pneumocysts causing spontaneous pneumothorax with the use of a carbon dioxide laser. However, it was laborious to use a carbon dioxide laser in thoracoscopic surgery because the handle was so rigid and large. Following the carbon dioxide laser, the Nd-YAG laser, which can be used with a thin flexible wire, was developed. The Nd-YAG laser was shown to be effective in sealing air leaks from the surface of the lung22 and was applied by Sharpe et al23 in 1994 in thoracoscopic treatment of spontaneous pneumothorax as a useful therapeutic option. The Nd-YAG laser has become the most common device employed for the treatment of pneumocysts. However, lasers are less ubiquitous and more expensive than electrosurgical units. Therefore, conventional inexpensive electrocautery is satisfactory as a second-line method for shrinking pneumocysts following stapled resection. The M-tip, which we applied in this study, can shrink the pleura as effectively and safely as the Nd-YAG laser in a human lung.14 The large ball tip is less curved than the conventional small tip, a design that allows the M-tip to treat a larger area.
Coagulation of the lung caused by ablation contributes to the shrinkage of the connective tissue, and so the reduced volume of the lung is limited.24 When a large pneumocyst is shrunk by heat, there still remains a downsized pneumocyst that may have the potential to cause pneumothorax. It is possible that resection is better than the M-tip for resecting a pneumocyst of > 2 cm. On the other hand, a small pneumocyst leaves little space inside following ablation and has coagulation of the parenchyma around it, so the potential for relapse may be low. As seen in this study, the relapse-free rate for patients who underwent ablation with the M-tip for large pneumocysts was approximately 64%. These data suggest that the application of electrocautery for pneumocysts is limited. Therefore, the use of ablation for a large pneumocyst without pleural treatment is not recommended. The relapse might be prevented if some pleural treatment had been applied. By contrast, there was no relapse of pneumothorax in patients who underwent ablation with the M-tip for only small pneumocysts following first-line stapled resection for pneumocysts. In the patients who underwent only first-line stapled resection for pneumocysts, 11% of patients had a relapse of pneumothorax within a year. This may show that we might have been able to notice remaining small pneumocysts after the stapled resection, and if we had found and ablated them during the operation, the relapse might have been prevented. The relapse rate of 11% for patients who underwent only stapled resection for pneumocysts seems to be high, and so pleurodesis might be recommended. However, the outcome of the pleuritis caused by pleurodesis remains unclear. Pleural adhesion will be a cause of restriction of respiration, and it will be difficult to operate on the patient to treat another disease. As a policy at our institutes, we do not indicate pleurodesis in the initial operation for patients with PSP, because pleurodesis is not necessary in > 90% of patients with PSP who underwent surgery.
| Conclusion |
|---|
|
|
|---|
| Footnotes |
|---|
This article was presented at CHEST 2000, San Francisco, CA, October 25, 2000.
Received for publication December 5, 2000. Accepted for publication May 31, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Sawabata, S.-I. Takeda, M. Inoue, M. Koma, T. Tokunaga, and H. Maeda M-tip electro-ablation of pneumo-cysts for treatment of spontaneous pneumothorax as a secondary method to stapling: a confirmation study Interactive CardioVascular and Thoracic Surgery, December 1, 2005; 4(6): 614 - 617. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |